COA COA-2026-953582 matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
LS9PB7CKThis is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 65 mg · Lab measured 68.1 mg
105% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 17 mg using the measured mass, against 16.3 mg on the label — 5% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | COA-2026-953582 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 24 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide from Unknown brand, performed by ILS Laboratories on July 9, 2026. Reported purity: 99.86%. Net content: 68.1 mg against 65 mg labeled (105% of label). Heavy metals: Arsenic (As): 0.614 ppm, Pass; Cadmium (Cd): Not Detected, Pass; Lead (Pb): 0.554 ppm, Pass; Mercury (Hg): Not Detected, Pass; Chromium (Cr): Not Detected, Pass. Batch 26-U4-ORT / ZE450422. Sample source: shop-provided. Certificate of analysis attached.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion